Menactra Vial Of 0.5 Ml Solution For Injection
By BIOLOGICAL E LIMITED
Refrigerated
0.5ml Solution For Injection in Vial
₹5016.00*
12% OFF
₹10032/ml
(Inclusive of all taxes)
15 days return policyRead More
All the Products are packed and stored Safely
Description
Menactra vaccine is indicated for active immunization against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135 in individuals aged 9 months to 55 years. It does not prevent disease caused by N. meningitidis serogroup B. Menactra is administered via intramuscular injection.
Some common side effects of this vaccine include reactions at the injection site, such as pain, swelling, or redness; irritability; loss of appetite; sleepiness; headache; nausea; vomiting; and diarrhea. If these side effects do not improve over time or worsen, inform your doctor.
Inform your doctor about any other illnesses you may have had before receiving the vaccine. Disclose all medications you are currently taking. Pregnant and breastfeeding mothers should consult their doctor for advice before getting the vaccine.
Product Summary
| Offer Price | ₹5016.00 |
| You Save | ₹684.00 (12% on MRP) |
| Contains | Diphtheria Toxoid+Meningococcal A, C, W And Y Conjugate Vaccine |
| Uses | Vaccine for meningococcal disease |
| Side effects | Pain at the injection site, headaches, fatigue, and injection site reactions. |
| Therapy | VACCINE |
Uses of MENACTRA VIAL OF 0.5 ML SOLUTION FOR INJECTION
Menactra vaccine is indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135 in individuals 9 months through 55 years of age. ...
Contraindications of MENACTRA VIAL OF 0.5 ML SOLUTION FOR INJECTION
- If you are allergic after a previous dose of a vaccine containing meningococcal capsular polysaccharide, diphtheria toxoid, or if you are allergic to any component of Menactra,
- If you have a moderate or severe fever or acute illness, vaccination should be postponed until you recover.
Side effects of MENACTRA VIAL OF 0.5 ML SOLUTION FOR INJECTION
- Children Aged 9 to 12 Months: The most frequently reported reactions were tenderness at the injection site and irritability.
- Individuals Aged 2 to 10 Years: The most frequently reported reactions included pain at the injection site and irritability. Diarrhea, drowsiness, and anorexia were also common.
- Adolescents Aged 11 to 18 Years and Adults Aged 18 to 55 Years: The most commonly reported reactions after a single dose were pain at the injection site, headache, fatigue and injection site reactions....
- Booster Vaccination for Ages 15 to 55 Years: The most common reactions were pain at the injection site and muscle pain.
Precautions and Warnings of MENACTRA VIAL OF 0.5 ML SOLUTION FOR INJECTION
Pregnancy
Q:
Can I take Menactra vaccine during pregnancy?
A:
Consult your doctor to discuss your specific situation and consider the potential benefits and risks of vaccination with Menactra during pregnancy.
Breast Feeding
Q:
Can I take Menactra vaccine while breastfeeding?
A:
Limited information is available about the use of Menactra vaccine during breastfeeding; it is essential to consult your physician before receiving this vaccine while breastfeeding.
Driving
Q:
Can I drive if I have consumed Menactra vaccine?
A:
Menactra vaccine has no or negligible influence on the ability to drive and use machines.
Alcohol
Q:
Can I consume alcohol with Menactra vaccine?
A:
Limited information is available on the interaction of alcohol with Menactra.
Other General Warnings
Talk to your doctor if
- You have kidney disease or have had a kidney transplant.
- You have liver disease or a history of significant liver problems.
- You have ever been diagnosed with Guillain-Barré Syndrome (GBS), as this condition may recur after vaccination.
- You have a bleeding disorder or low platelet count (thrombocytopenia), as the vaccine is administered intramuscularly and could pose a bleeding risk.
- You are taking immunosuppressive medication or have a weakened immune system due to illness or treatment, the vaccine may not be as effective for you.
- You have a history of severe allergic reactions to any vaccine or its components.
- You tend to faint easily after injections (fainting or “syncope” has been reported after this vaccine). Precautions should be taken to avoid injury.
Directions for Use of MENACTRA VIAL OF 0.5 ML SOLUTION FOR INJECTION
- Menactra vaccine is administered as a single 0.5 mL dose via intramuscular injection, preferably in the anterolateral thigh for infants and young children and in the deltoid region for older individuals....
- For children aged 9 to 23 months: A 2-dose series is required, with doses at least three months apart. For individuals aged 2 to 55 years: A single dose is sufficient.
- Booster Vaccination (ages 15 to 55 years): A single booster dose may be given if at least 4 years have elapsed since the previous dose and the individual remains at ongoing risk for meningococcal disease....
Storage and disposal of MENACTRA VIAL OF 0.5 ML SOLUTION FOR INJECTION
Store it in a refrigerator at 2-8 °c. Keep this out of children's sight.
Dosage of MENACTRA VIAL OF 0.5 ML SOLUTION FOR INJECTION
Overdose
Chances of an overdose are unlikely since this will be given to your child under medical supervision.
Missed a Dose
If your child misses an injection that is due, it is important that you make another appointment. Make sure your child finishes the complete vaccination course. If not, your child may not be fully protected against the diseases....
Mode of Action of MENACTRA VIAL OF 0.5 ML SOLUTION FOR INJECTION
How Does It Work?
Menactra vaccine works by stimulating the body's immune system to produce bactericidal antibodies specifically against the capsular polysaccharides of Neisseria meningitidis serogroups A, C, Y, and W-135. The presence of these antibodies has been associated with protection from invasive meningococcal disease....
Interactions of MENACTRA VIAL OF 0.5 ML SOLUTION FOR INJECTION
Interactions with other medicines
Immunosuppressive Therapies: Immunosuppressive therapies, including irradiation, antimetabolites, alkylating agents, cytotoxic drugs, and corticosteroids (administered in doses greater than physiologic) may reduce the immune response to the Menactra vaccine....
Content Details
WRITTEN BY
Ravindra Ghongade
B. Pharm
REVIEWED BY
Dr. Nikita Toshi
BDS (Bachelor of Dental Surgery), WHO FIDES member
Frequently Asked Questions (FAQs)
Q: Can Menactra vaccine cause side effects?
A: Yes, like all vaccines, it can have side effects. The most common include redness, pain, or swelling at the injection site, and possibly some fussiness, headaches, or tiredness. Serious allergic reactions are rare but possible.
Q: Who should not receive the Menactra vaccine?
A: Individuals who have experienced a severe allergic reaction to a previous meningococcal, diphtheria, or similar vaccine, or to any component of the Menactra vaccine, should not receive it. If you have a moderate or severe fever or illness, it is advisable to wait until you are feeling better.
Q: Does Menactra vaccine protect against all types of meningitis?
A: No, it protects against four types (A, C, Y, and W-135) but not against type B.
Q: Can I receive the Menactra vaccine if I'm pregnant or breastfeeding?
A: There is some information suggesting it may be okay, but it is best to consult your doctor to weigh the benefits and risks for you and your baby.
Q: What should I do if I miss a dose?
A: If you miss a dose, consult your doctor about when you should receive it.
Q: Can Menactra vaccine interact with other vaccines or medicines?
A: It can be administered with certain other vaccines, but they should be given in separate injections at different sites on the body. Some medications that weaken your immune system might reduce the vaccine's effectiveness. Inform your doctor about all the medications you are taking.
Q: What should I do if I experience a reaction after receiving the Menactra vaccine?
A: Inform your doctor if you have any serious or unusual reactions. If you experience signs of a severe allergic reaction (such as hives, swelling, or difficulty breathing), seek medical assistance immediately.
References
View All
- Menveo Group A,C, W135 and Y conjugate vaccine - Summary of Product Characteristics (SmPC) - (emc) [Internet]. www.medicines.org.uk. Cited [14th April 2015]
- Package Insert - Menactra | FDA [Internet]. Fda.gov. 2025 [cited 2025 Apr 14].
- Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine Menactra ® [Internet]. [cited 2025 Apr 14].
Did you find this medicine information helpful?
Please rate your experience
Product Details
Brand
MENACTRA
Country of Origin
India
Expires on or After
29/06/2026
Health Articles
Disclaimer
The information provided herein is supplied to the best of our abilities to make it accurate and reliable as it is published after a review by a team of professionals. This information is solely intended to provide a general overview on the product and must be used for informational purposes only. You should not use the information provided herein to diagnose, prevent, or cure a health problem. Nothing contained on this page is intended to create a doctor-patient relationship, replace or be a substitute for a registered medical practitioner's medical treatment/advice or consultation. The absence of any information or warning to any medicine shall not be considered and assumed as an implied assurance. We highly recommend that you consult your registered medical practitioner for all queries or doubts related to your medical condition. You hereby agree that you shall not make any health or medical-related decision based in whole or in part on anything contained in the Site. Please click here for detailed T&C.
Please add item(s) to proceed
Top-Tests we cover:
Top-Selling Healthcare Products:
Top-Selling Medicines:
Top-Searched Medicines:
